StockWatch
·

BERYL DRUGS LTD.

BSE: 524606

Shareholding Trends

Ownership split

PromoterPublicOthers
0%27%55%82%Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%0%1%1%Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingBERLDRG
2026
14Nov

Board Meeting

To consider and approve Unaudited Financial Results for the …

BSE Filing ↗
Board MeetingBERLDRG
2026
29Sep

Board Meeting

The company is providing facilities to the members to cast t…

BSE Filing ↗
Board MeetingBERLDRG
2026
2Sep

Board Meeting

The Board Meeting is scheduled to consider and approve the B…

BSE Filing ↗
Board MeetingBERLDRG
2026
11Aug

Board Meeting

To consider and approve the unaudited financial results for …

BSE Filing ↗
Board MeetingBERLDRG
2026
28May

Board Meeting

To consider and approve the Audited Financial Statement incl…

BSE Filing ↗
Board MeetingBERLDRG
2026
1Apr

Board Meeting

To consider and approve the date and notice of an Extra Ordi…

BSE Filing ↗
Board MeetingBERLDRG
2025
30May

Board Meeting

Consider & approve Audited Financial Results, take on record…

BSE Filing ↗
Board MeetingBERLDRG
2024
13Nov

Board Meeting

Consider Unaudited Financial Results (UFR Q2) and Limited Re…

BSE Filing ↗
Board MeetingBERLDRG
2024
3Sep

Board Meeting

Consider and approve the Board report and other matters rela…

BSE Filing ↗